Clinical Trial Update: Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating autologous bone marrow-derived mononuclear cells to promote therapeutic arteriogenesis in patients with limb ischemia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Autologous bone marrow-derived mononuclear cells (bone marrow-derived mononuclear cells)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Intermittent Claudication, Peripheral Vascular Diseases | Phase 2, Phase 3 | Status: UNKNOWN